Table 1.
ΔH*a | ΔS*a | ΔG*b | |
---|---|---|---|
kJ/mol | J/mol K | kJ/mol | |
ApoA-I 1–83/G26R | |||
Nucleation (k1) | 126 ± 20 | 55 ± 14 | 109 |
Fibril growth (k2) | 65 ± 6 | −122 ± 33 | 103 |
Δ32–40 | |||
Nucleation (k1) | 77 ± 12 | −122 ± 64 | 115 |
Fibril growth (k2) | 87 ± 22 | −47 ± 14 | 102 |
Δ50–58 | |||
Nucleation (k1) | 22 ± 14 | −281 ± 160 | 110 |
Fibril growth (k2) | 98 ± 6 | −20 ± 2 | 104 |
Δ68–76 | |||
Nucleation (k1) | 137 ± 16 | 70 ± 14 | 115 |
Fibril growth (k2) | 47 ± 10 | −170 ± 45 | 100 |
a ΔH* and ΔS* were obtained from the slope and y-intercept of the linear plot, respectively, according to Equation 3.
b ΔG* was calculated from ΔH* and ΔS* according to ΔG* = ΔH* − TΔS* at 37 °C.